Lymphoid-tissue Stromal Cells Coordinate Innate Defense to Cytomegalovirus

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2013 Mar 29

PMID 23536654

Citations 19

Authors

Shilpi Verma

Qiao Wang

Grzegorz Chodaczek

Chris A Benedict

Affiliations

Soon will be listed here.

Abstract

During mouse cytomegalovirus (MCMV) infection, the first wave of type I interferon (IFN-I) production peaks at ≈ 8 h. This IFN-I emanates from splenic stromal cells located in the marginal zone (MZ) and requires B cells that express lymphotoxin. The amount of IFN-I produced at these initial times is at least equivalent in magnitude to that produced later by dendritic cells (≈ 36 to 48 h), but the relative roles of these two IFN-I sources in regulating MCMV defense remain unclear. Here we show that IFN-I produced by MZ stromal cells dramatically restricts the first measurable burst of viral production, which occurs at ≈ 32 h. This primary innate control by IFN-I is partially mediated through the activation of natural killer (NK) cells, which produce gamma interferon in an IFN-I-dependent fashion, and is independent of Ly49H. Strikingly, MCMV production in the spleens of immunocompetent mice never increases at times after 32 h. These results highlight the critical importance of lymphoid-tissue stromal cells in orchestrating the earliest phase of innate defense to MCMV infection, capping replication levels, and blocking spread until infection is ultimately controlled.

Citing Articles

Tissue-specific features of innate lymphoid cells in antiviral defense.

Piersma S Cell Mol Immunol. 2024; 21(9):1036-1050.

PMID: 38684766 PMC: 11364677. DOI: 10.1038/s41423-024-01161-x.

Late-rising CD4 T cells resolve mouse cytomegalovirus persistent replication in the salivary gland.

Brunel S, Picarda G, Gupta A, Ghosh R, McDonald B, El Morabiti R PLoS Pathog. 2024; 20(1):e1011852.

PMID: 38236791 PMC: 10796040. DOI: 10.1371/journal.ppat.1011852.

Chronic alcohol consumption exacerbates murine cytomegalovirus infection via impairing nonspecific and specific NK activation in mice.

Little A, Li Y, Zhang F, Zhang H FASEB Bioadv. 2020; 1(1):18-31.

PMID: 32123809 PMC: 6996384. DOI: 10.1096/fba.1019.

Vaccine Vectors Harnessing the Power of Cytomegaloviruses.

Ynga-Durand M, Dekhtiarenko I, Cicin-Sain L Vaccines (Basel). 2019; 7(4).

PMID: 31627457 PMC: 6963789. DOI: 10.3390/vaccines7040152.

Life-long control of cytomegalovirus (CMV) by T resident memory cells in the adipose tissue results in inflammation and hyperglycemia.

Contreras N, Sitnik K, Jeftic I, Coplen C, Cicin-Sain L, Nikolich-Zugich J PLoS Pathog. 2019; 15(6):e1007890.

PMID: 31220189 PMC: 6605679. DOI: 10.1371/journal.ppat.1007890.

References

Orange J, Biron C . Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol. 1996; 156(12):4746-56. View

Blanc M, Hsieh W, Robertson K, Watterson S, Shui G, Lacaze P . Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol. 2011; 9(3):e1000598. PMC: 3050939. DOI: 10.1371/journal.pbio.1000598. View

Henry S, Schmader K, Brown T, Miller S, Howell D, Daley G . Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J Virol Methods. 2000; 89(1-2):61-73. DOI: 10.1016/s0166-0934(00)00202-0. View

Presti R, Pollock J, Dal Canto A, OGuin A, Virgin 4th H . Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med. 1998; 188(3):577-88. PMC: 2212470. DOI: 10.1084/jem.188.3.577. View

Ware C, Benedict C . Innate B cells: oxymoron or validated concept?. F1000Res. 2013; 1:8. PMC: 3751138. DOI: 10.12688/f1000research.1-8.v1. View

Schattgen S, Fitzgerald K . The PYHIN protein family as mediators of host defenses. Immunol Rev. 2011; 243(1):109-18. DOI: 10.1111/j.1600-065X.2011.01053.x. View

Hsu K, Pratt J, Akers W, Achilefu S, Yokoyama W . Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol. 2008; 90(Pt 1):33-43. PMC: 2762738. DOI: 10.1099/vir.0.006668-0. View

Baranek T, Vu Manh T, Alexandre Y, Maqbool M, Cabeza J, Tomasello E . Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe. 2012; 12(4):571-84. DOI: 10.1016/j.chom.2012.09.002. View

Banks T, Rickert S, Benedict C, Ma L, Ko M, Meier J . A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection. J Immunol. 2005; 174(11):7217-25. DOI: 10.4049/jimmunol.174.11.7217. View

10.

Sheehan K, Lai K, Dunn G, Bruce A, Diamond M, Heutel J . Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J Interferon Cytokine Res. 2006; 26(11):804-19. DOI: 10.1089/jir.2006.26.804. View

11.

Honke N, Shaabani N, Cadeddu G, Sorg U, Zhang D, Trilling M . Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol. 2011; 13(1):51-7. DOI: 10.1038/ni.2169. View

12.

Ware C . Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol. 2005; 23:787-819. DOI: 10.1146/annurev.immunol.23.021704.115719. View

13.

Zucchini N, Bessou G, Traub S, Robbins S, Uematsu S, Akira S . Cutting edge: Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J Immunol. 2008; 180(9):5799-803. DOI: 10.4049/jimmunol.180.9.5799. View

14.

Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, Fujita T . Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 1998; 17(4):1087-95. PMC: 1170457. DOI: 10.1093/emboj/17.4.1087. View

15.

Prakash A, Smith E, Lee C, Levy D . Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem. 2005; 280(19):18651-7. PMC: 1167601. DOI: 10.1074/jbc.M501289200. View

16.

Krug A, French A, Barchet W, Fischer J, Dzionek A, Pingel J . TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 2004; 21(1):107-19. DOI: 10.1016/j.immuni.2004.06.007. View

17.

Smith H, Heusel J, Mehta I, Kim S, Dorner B, Naidenko O . Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A. 2002; 99(13):8826-31. PMC: 124383. DOI: 10.1073/pnas.092258599. View

18.

Reddehase M, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski U . The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med. 1994; 179(1):185-93. PMC: 2191331. DOI: 10.1084/jem.179.1.185. View

19.

Reddehase M, Podlech J, Grzimek N . Mouse models of cytomegalovirus latency: overview. J Clin Virol. 2002; 25 Suppl 2:S23-36. DOI: 10.1016/s1386-6532(02)00087-2. View

20.

Zucchini N, Bessou G, Robbins S, Chasson L, Raper A, Crocker P . Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int Immunol. 2007; 20(1):45-56. PMC: 7110020. DOI: 10.1093/intimm/dxm119. View